Moonlake Immunotherapeutics (MLTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2020 | 12-2017 | 12-2006 | |
| Assets | |||
| Current Assets | |||
| Cash & Cash Equivalents | 1,336 | N/A | N/A |
| TOTAL | $1,619 | $N/A | $N/A |
| Non-Current Assets | |||
| Investments And Advances | 115,015 | 0 | 0 |
| TOTAL | $115,015 | $N/A | $N/A |
| Total Assets | $116,634 | $N/A | $N/A |
| Liabilities | |||
| Current Liabilities | |||
| Accrued Expenses | 67 | N/A | N/A |
| TOTAL | $125 | $N/A | $N/A |
| Non-Current Liabilities | |||
| Other Non-Current Liabilities | 115,000 | 0 | 0 |
| TOTAL | $119,025 | $N/A | $N/A |
| Total Liabilities | $119,150 | $N/A | $N/A |
| Shareholders' Equity | |||
| Shares Outstanding, K | 14,805 | N/A | N/A |
| Retained earnings | -2,517 | N/A | N/A |
| TOTAL | $-2,516 | $N/A | $N/A |
| Total Liabilities And Equity | $116,634 | $0 | $0 |